Group 4A: Breast Cancer; Immunotherapy; Clinical Trials

Poster #TPS2683: First-in-human autologous CAR-T for metastatic breast cancers to target growth factor receptor MUC1*.

Poster #532: Dose-dense adjuvant chemotherapy in patients with HER2-low early breast cancer: An exploratory analysis of the GIM2 trial.